Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients. Donnette M, Hamimed M, Ciccolini J, Sicard G, et al. Br J Haematol 2023;203:625-636.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Donnette M, Hamimed M, Ciccolini J, Sicard G, et al. Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients. Br J Haematol 2023;203:625-636.
PMID: 37691342